A detailed history of Telemetry Investments, L.L.C. transactions in Verastem, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 225,000 shares of VSTM stock, worth $587,250. This represents 0.14% of its overall portfolio holdings.

Number of Shares
225,000
Previous 187,500 20.0%
Holding current value
$587,250
Previous $159,000 42.77%
% of portfolio
0.14%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.33 - $10.44 $12,375 - $391,500
37,500 Added 20.0%
225,000 $91,000
Q3 2022

Nov 17, 2022

BUY
$0.92 - $11.16 $16,100 - $195,300
17,500 Added 10.29%
187,500 $159,000
Q2 2022

Aug 15, 2022

BUY
$1.02 - $1.83 $35,700 - $64,050
35,000 Added 25.93%
170,000 $197,000
Q1 2022

May 16, 2022

BUY
$1.06 - $2.1 $143,100 - $283,500
135,000 New
135,000 $190,000
Q4 2021

Feb 14, 2022

SELL
$2.05 - $3.2 $133,250 - $208,000
-65,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.54 - $4.07 $165,100 - $264,550
65,000 New
65,000 $200,000
Q2 2021

Aug 16, 2021

SELL
$2.57 - $4.85 $192,750 - $363,750
-75,000 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$1.9 - $2.82 $57,000 - $84,600
-30,000 Reduced 28.57%
75,000 $185,000
Q4 2020

Feb 16, 2021

SELL
$1.15 - $2.4 $63,249 - $132,000
-55,000 Reduced 34.38%
105,000 $224,000
Q3 2020

Nov 16, 2020

BUY
$1.11 - $1.68 $68,820 - $104,160
62,000 Added 63.27%
160,000 $194,000
Q2 2020

Aug 14, 2020

SELL
$1.69 - $4.2 $31,722 - $78,838
-18,771 Reduced 16.08%
98,000 $169,000
Q1 2020

May 15, 2020

BUY
$1.26 - $3.38 $147,131 - $394,685
116,771 New
116,771 $308,000
Q4 2019

Feb 14, 2020

SELL
$0.86 - $1.44 $98,556 - $165,024
-114,600 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.59 $36,784 - $48,336
-30,400 Reduced 20.97%
114,600 $139,000
Q2 2019

Aug 14, 2019

BUY
$1.25 - $3.14 $181,250 - $455,300
145,000 New
145,000 $219,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $548M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.